Structural information of Plasmodium falciparum S-adenosyl-L-homocysteine hydrolase (PfSAHH) has been expected to provide new-type chemotherapeutic agents against malaria. Here we report the crystal structure of PfSAHH. The present structure should provide opportunities to design potent and selective PfSAHH inhibitors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/nass/48.1.281 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dysmorphic Findings in SAHH Deficiency with a Novel Variant in the Gene.
Mol Syndromol
December 2024
Department of Medical Genetics, University of Health Sciences, Van Training and Research Hospital, Van, Turkey.
Introduction: S-adenosylhomocysteine hydrolase (SAHH) is one of the enzymes involved in converting methionine to homocysteine with transmethylation processes. Methyltransfer reactions are impaired in SAHH deficiency. SAHH deficiency is multisystemic and antenatal onset disorder.
View Article and Find Full Text PDFS-adenosylmethionine and S-adenosyl-L-homocysteine metabolism is involved in the sperm motility and in vitro fertility rate in mouse.
Biochem Biophys Res Commun
December 2024
Department of Cellular Physiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; Neutron Therapy Research Center, Okayama University, Okayama, Japan. Electronic address:
Increased fragmentation of sperm DNA has been implicated in male infertility. Folate deficiency results in impaired methionine synthesis, depletion of S-adenosylmethionine (SAM) levels, an increase in S-adenosyl-l-homocysteine (SAH) levels, and increased DNA fragmentation. Disruption of the dynamic balance between SAM and SAH may also contribute, although the details of this process are not yet fully understood.
View Article and Find Full Text PDF5'-Noraristeromycin Repurposing: Well-known S-Adenosyl-L-homocysteine Hydrolase Inhibitor As a Potential Drug Against Leukemia.
Acta Naturae
January 2024
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russian Federation.
Article Synopsis
- 5'-Noraristeromycin, a mixture of two enantiomers, has strong cytotoxic effects on leukemia cells, with different effectiveness across cell lines (Jurkat, K562, THP-1).
- In toxicity studies on white mice, the lethal dose (LD) of 5'-noraristeromycin was found to be around 63.2 mg/kg, with notable doses causing varying levels of acute toxicity.
- Administering this substance leads to systemic damage to the internal organs and tissues of the mice, indicating significant health risks at certain dosage levels.
Computational-driven discovery of AI-2 quorum sensing inhibitor targeting the 5'- methylthioadenosine/S-adenosylhomocysteine nucleosidase (MTAN) to combat drug-resistant Helicobacter pylori.
Comput Biol Med
January 2025
Central Research Laboratory, KS Hegde Medical Academy, Nitte (Deemed to be University), Mangalore, 575018, Karnataka, India; Center for Bioinformatics and Biostatistics, Nitte (Deemed to be University), Mangalore, 575018, Karnataka, India. Electronic address:
MTAN is an attainable therapeutic target for H. pylori because it may minimize virulence production, limit resistance, and impair quorum sensing without affecting gut flora. Here, 457 compounds with anti-H.
View Article and Find Full Text PDFAsymptomatic pediatric presentation of S-adenosylhomocysteine hydrolase deficiency.
JIMD Rep
November 2024
Article Synopsis
- S-adenosylhomocysteine hydrolase deficiency is an autosomal recessive metabolic disorder disrupting the methionine cycle, which can range from severe symptoms to asymptomatic cases.
- Two clinically asymptomatic siblings from Pakistan were diagnosed with mild chronic liver failure and other mild symptoms, with one sibling showing improvements after dietary changes.
- The research highlights a specific genetic variant common in South Asia and suggests this milder form of the disease may be underdiagnosed, emphasizing the need for better therapeutic management to prevent future health complications.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!